Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can genetic testing and regular checkups predict Children's future health?

NCT ID NCT06802029

Knowledge-focused Sponsor: Puer Research, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers want to learn how children's health changes over time and which tests best detect those changes. The study enrolls children ages 6 to under 18 who have a parent with a known genetic variant or who have unexplained health issues. Participants undergo whole genome sequencing and regular physical assessments to build a personal health baseline, then researchers monitor for new deviations over up to three years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Whole genome sequencing analysis
What this could lead to
If this works, it could help doctors spot health changes in children earlier and understand which tests are best for tracking long-term health.
What could go wrong
This is an observational study with no treatment, so it cannot prove that any test improves health. It may not find meaningful patterns, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Started

Sep 2025

Finished

Jul 2026

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male or non-pregnant female; age 6 to less than 18.

Ages

6 to 18 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: To participate in the study, patients must meet the following criteria: 1. Male or non-pregnant female; age 6 to less than 18. 2. Females of childbearing potential (WOCBP) must have a negative urine pregnancy test (UPT) at all visits. 3. Presence of 1. At least one pathogenic genetic variant in a biological parent, which is annotated as pathogenic in at least one public database, such as dbSNP, ClinVar, VEP (variant effect predictor), etc.; OR 2. Presence of unexplained disease, illness, trait, or phenotype. 4. Approval is at the sole discretion of the sponsor. Exclusion Criteria: Patients who meet any of the following criteria will be excluded from study participation: 1. Unwillingness or inability to participate in the study. 2. Unwillingness or inability to provide assent as per inclusion criterion #1, including those who lack the capacity to provide assent and will obtain 18 years of age prior to completion of the study. 3. WOCBP a with positive pregnancy test at enrollment or at any visit.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aging

Contacts and locations

Locations

  • Puer Research, LLC

    Atlanta, Georgia, 30350, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.